Neuromuscular DiseaseInfo Center

New Parkinson's Rx Gets FDA Nod
The US Food and Drug Administration (FDA) has approved an add-on therapy for patients with Parkinson's disease.
Epilepsy Rx: Old Vs. New
Some older patients with a new epilepsy diagnosis may be getting older anti-epileptic drugs (AEDs), which could have more side effects and potential drug interactions than the new ones, according to a new study.
Lots of Kids May Have Aching Backs
Lower back pain in school-aged children may be common, according to a new study.
The Benefits of Using Your Brain
Older adults who do brain-stimulating activities may see big benefits for their mental function, according to a new study.
A New Rx for Duchenne Muscular Dystrophy
The US Food and Drug Administration (FDA) has approved a new medication for the most common type of muscular dystrophy.
New Pain Rx Gets FDA Nod
The US Food and Drug Administration has approved a new treatment for severe and long-lasting (chronic) pain.
New Pain Rx Gets Green Light
The US Food and Drug Administration has approved a new treatment for severe and long-lasting (chronic) pain.
Approved: First Rx for Spinal Muscular Atrophy
The US Food and Drug Administration (FDA) has approved the first drug to treat spinal muscular atrophy (SMA).
What You Should Know About Opioids
Deadly opioid overdoses are still on the rise in the United States, according to the Centers for Disease Control and Prevention (CDC). Here's what you should know.
How Walking Might Help Those on Dialysis
A home-based walking program could benefit patients on dialysis both physically and mentally, a new study found.